Shanghai MicroPort Endovascular MedTech Group Co Ltd (MicroPort Endovascular MedTech), a subsidiary of MicroPort Scientific Corp, specializes in the research, development, manufacturing, sales, and services of aortic and peripheral vascular intervention devices. The company's product portfolio includes thoracic and abdominal aortic stent grafts, stent-grafts in surgical operations, drug-coated balloon dilatation catheters, peripheral vascular stents, and balloon dilatation catheters. The company operates under the brands Endovastec, Castor, Hercules, Minos, Aegis, CRONUS, Fontus and Talos. MicroPort Endovascular MedTech products are used in hospitals for the treatment of peripheral venous diseases, peripheral arterial diseases, and tumors. The company distributes its products through a network of hospitals in both domestic and international markets in Europe, Latin America, and Southeast Asia. MicroPort Endovascular MedTech is headquartered in Shanghai, China.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Shanghai MicroPort Endovascular MedTech Co Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Shanghai MicroPort Endovascular MedTech Co Ltd Company Overview
- Shanghai MicroPort Endovascular MedTech Co Ltd Company Snapshot
- Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Shanghai MicroPort Endovascular MedTech Co Ltd - Pipeline Analysis Overview
- Shanghai MicroPort Endovascular MedTech Co Ltd - Key Facts
- Shanghai MicroPort Endovascular MedTech Co Ltd - Major Products and Services
- Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Development Stage
- Shanghai MicroPort Endovascular MedTech Co Ltd Ongoing Clinical Trials by Trial Status
- Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products Overview
- Aortic Vascular Intervention Device
- Aortic Vascular Intervention Device Product Overview
- Cratos Branched Aortic Stent Graft System
- Cratos Branched Aortic Stent Graft System Product Overview
- Cratos Branched Aortic Stent Graft System Clinical Trial
- Multi-Branch Aortic Stent
- Multi-Branch Aortic Stent Product Overview
- Peripheral Vascular Intervention Device
- Peripheral Vascular Intervention Device Product Overview
- Thrombectomy Catheter
- Thrombectomy Catheter Product Overview
- TIPS Stent Graft System
- TIPS Stent Graft System Product Overview
- TIPS Stent Graft System Clinical Trial
- Venous Stent
- Venous Stent Product Overview
- Vewatch
- Vewatch Product Overview
- Vflower Venous Stent System
- Vflower Venous Stent System Product Overview
- Vflower Venous Stent System Clinical Trial
- Shanghai MicroPort Endovascular MedTech Co Ltd - Key Competitors
- Shanghai MicroPort Endovascular MedTech Co Ltd - Key Employees
- Shanghai MicroPort Endovascular MedTech Co Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- Shanghai MicroPort Endovascular MedTech Co Ltd, Recent Developments
- Apr 07, 2024: MicroPort Endovastec Completes Its First Implantation of Cratos in Pre-Market Clinical Study in the EU and Japan
- Mar 29, 2023: Endovastec Announces Annual Results for 2022
- Jan 02, 2023: Endovastec completes first pre-market clinical implantation of TIPS Stent Graft System
- Aug 25, 2022: Endovastec Announces 2022 Interim Results 25 Aug 2022
- Apr 11, 2022: Endovastec receives MDSAP certificate for Brazil and Japan
- Mar 29, 2022: Endovastec announces annual results for 2021
- Mar 28, 2022: Hyperflex balloon catheter by Endovastec receives marketing approval in Japan
- Nov 11, 2021: Vflower, first venous stent system by MicroPort Endovastec, gains access to China’s special approval procedure for innovative medical devices
- Oct 16, 2021: Shanghai MicroPort Endovascular MedTech: Clinical trial enrollment completed for the first Endovastec Venous Stent
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Equipment Type
- Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Indication
- Shanghai MicroPort Endovascular MedTech Co Ltd Ongoing Clinical Trials by Trial Status
- Shanghai MicroPort Endovascular MedTech Co Ltd, Key Facts
- Shanghai MicroPort Endovascular MedTech Co Ltd, Major Products and Services
- Shanghai MicroPort Endovascular MedTech Co Ltd Number of Pipeline Products by Development Stage
- Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products Summary by Development Stage
- Shanghai MicroPort Endovascular MedTech Co Ltd Ongoing Clinical Trials by Trial Status
- Shanghai MicroPort Endovascular MedTech Co Ltd Ongoing Clinical Trials Summary
- Aortic Vascular Intervention Device - Product Status
- Aortic Vascular Intervention Device - Product Description
- Cratos Branched Aortic Stent Graft System - Product Status
- Cratos Branched Aortic Stent Graft System - Product Description
- Cratos Branched Aortic Stent Graft System - A Prospective, Multicenter, Single-group Clinical Trial to Evaluate the Efficacy and Safety of the Cratos Branch Aortic Covered Stent System in the Treatment of Stanford Type B Aortic Dissection
- Cratos Branched Aortic Stent Graft System - Evaluation of Cratos Branch Stent Graft System in Treatment of Descending Aorta Lesions
- Multi-Branch Aortic Stent - Product Status
- Multi-Branch Aortic Stent - Product Description
- Peripheral Vascular Intervention Device - Product Status
- Peripheral Vascular Intervention Device - Product Description
- Thrombectomy Catheter - Product Status
- Thrombectomy Catheter - Product Description
- TIPS Stent Graft System - Product Status
- TIPS Stent Graft System - Product Description
- TIPS Stent Graft System - A Prospective, Multicenter, Single-group, Target-value Trial to Evaluate the Safety and Efficacy of Tips Coated Stent System in the Treatment of Portal Hypertension
- Venous Stent - Product Status
- Venous Stent - Product Description
- Vewatch - Product Status
- Vewatch - Product Description
- Vflower Venous Stent System - Product Status
- Vflower Venous Stent System - Product Description
- Vflower Venous Stent System - Pre-market Multicenter Clinical Trial of the Vflower Venous Stent System
- Shanghai MicroPort Endovascular MedTech Group Co Ltd, Key Employees
- Glossary
- Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Equipment Type
- Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products by Development Stage
- Shanghai MicroPort Endovascular MedTech Co Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Teleflex Medical Trading (Shanghai) Co Ltd
- Shinva Medical Instrument Co Ltd
- Shanghai INT Medical Instruments Co Ltd
- Lepu Medical Technology (Beijing) Co Ltd
- Autocam Medical
